2000
DOI: 10.1016/s0378-1097(99)00607-2
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of cefminox by cell-free extracts of Streptomyces clavuligerus

Abstract: In vitro synthesis of cefminox by cell-free extracts of Streptomyces clavuligerus was investigated using K-ketoglutarate, L-ascorbic acid, FeSO 4 , S-adenosyl-L-methionine, and 7K-demethoxycefminox as the substrates. The formation of cefminox was detected both by a biological assay with Proteus vulgaris GN 76/C-1 and by high performance liquid chromatography. Although the conversion rate of 7K-demethoxycefminox to cefminox was observed to be quite low, it still demonstrated the potential for an enzymatic proce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…Expression of the novel pathway was done in P. furianosis , which has optimal activity at 100°C; when the cell‐free reaction was run at 70°C, only the recombinantly expressed enzymes were active at the lower temperature. Crude extracts have demonstrated the ability to synthesize high‐value biologics and therapeutics; examples include single‐step conversion of diketides to chiral triketide lactones (polyketide building blocks) [75], lysine to ϵ‐poly‐L‐lysine (an antimicrobial) [76], and 7α‐demethoxycefminox to cefminox (an antibiotic) [77]. In another study, 14 C‐labeled substrates were used to elucidate possible biosynthetic pathways for manufacture of the antitumor agent Azinomycin B [78].…”
Section: Achievements In Cell‐free Metabolic Engineering (Cfme)mentioning
confidence: 99%
“…Expression of the novel pathway was done in P. furianosis , which has optimal activity at 100°C; when the cell‐free reaction was run at 70°C, only the recombinantly expressed enzymes were active at the lower temperature. Crude extracts have demonstrated the ability to synthesize high‐value biologics and therapeutics; examples include single‐step conversion of diketides to chiral triketide lactones (polyketide building blocks) [75], lysine to ϵ‐poly‐L‐lysine (an antimicrobial) [76], and 7α‐demethoxycefminox to cefminox (an antibiotic) [77]. In another study, 14 C‐labeled substrates were used to elucidate possible biosynthetic pathways for manufacture of the antitumor agent Azinomycin B [78].…”
Section: Achievements In Cell‐free Metabolic Engineering (Cfme)mentioning
confidence: 99%
“…The industrial production of 7a-methoxycephalosporins is carried out by chemical synthesis using 7a-methoxycephalosporin C (MCPC) as the main precursor (Kobayashi et al 1977;Elander 2003). Because the conventional process to obtain MCPC is the chemical conversion of the more abundant substrate cephalosporin C (CPC), which is inefficient and expensive, biotransformation of CPC to MCPC was considered as a potential alternative enzymatic method for the industrial production of 7a-methoxycephalosporins (O'Sullivan and Abraham 1980;Hood et al 1983;Kim et al 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Its rapid growth rate, which has been linked to high rates of protein synthesis 5 and metabolic efficiency 6,7 suggests that this host may be harnessed as a powerful cell-free expression system. Cell-free bioproduction of protein and chemicals has been extensively investigated in E. coli and recently expanded to several other bacteria [8][9][10][11][12][13] . Accordingly, we assessed V. natriegens crude cell extract productivity in small-scale batch reactions using super-folder GFP (sfGFP) controlled by a T7 promoter.…”
mentioning
confidence: 99%